HeadlineShine

Eli Lilly is about to report earnings. Here's what to expect

CNBCEli Lilly is about to report earnings. Here's what to expect
Image: CNBC

Eli Lilly is slated to report third-quarter earnings and revenue, which will likely be fueled by its obesity drug Zepbound and diabetes counterpart Mounjaro.

Summary from CNBC

Read the full story on CNBC
React

Trending now

More business

See all →

Top stories in the United States

See all →